Grisanti S, Tura A. Uveal Melanoma. In Scott JF, Gerstenblith MR, eds. Noncutaneous Melanoma [Internet]. Brisbane (AU): Codon Publications; 2018. Accessed at https://www.ncbi.nlm.nih.gov/books/NBK506988/ on April 8, 2025.
Harbour JW, Shih HA. Initial management of uveal and conjunctival melanomas. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/initial-management-of-uveal-and-conjunctival-melanomas on April 8, 2025.
Houghton O, Gordon K. Chapter 64: Ocular Tumors. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa. Elsevier: 2020.
International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 118: Welding, Molybdenum Trioxide, and Indium Tin Oxide. 2018. Accessed at https://publications.iarc.fr/569 on April 8, 2025.
Masoomian B, Shields JA, Shields CL. Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma. J Curr Ophthalmol. 2018;30(2):102-109.
Mahendraraj K, Lau CS, Lee I, Chamberlain RS. Trends in incidence, survival, and management of uveal melanoma: A population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973–2012). Clinical Ophthalmology (Auckland, NZ). 2016;10:2113-2119.
National Cancer Institute. Intraocular (Uveal) Melanoma Treatment (PDQ®)–Health Professional Version. 2024. Accessed at https://www.cancer.gov/types/eye/hp/intraocular-melanoma-treatment-pdq on April 8, 2025.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Melanoma: Uveal. V.1.2025. Accessed at https://www.nccn.org on April 8, 2025.
Sullivan RJ, Shoushtari AN. The molecular biology of melanoma. UpToDate. 2025. Accessed at https://www.uptodate.com/contents/the-molecular-biology-of-melanoma on April 8, 2025.